Modulation of toll-like receptor 2 expression by antisense oligonucleotides

Details for Australian Patent Application No. 2009313600 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Bhagat, Lakshmi; Putta, Mallikarjuna; Kandimalla, Ekambar; Wang, Daqing; Yu, Dong; Agrawall, Sudhir

Agent Freehills

Pub. Number AU-A-2009313600

PCT Pub. Number WO2010/053971

Priority 61/111,143 04.11.08 US

Filing date 4 November 2009

Wipo publication date 14 May 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/053971 Priority application(s): WO2010/053971

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313602-Exploitation of deformation mechanisms for industrial usage in thin product forms

2009313598-Method of reducing the viscosity of hydrocarbon fluids